HaemaLogiX
PRIVATE
STATUS
1-10
EMPLOYEES
Accelerator/Inc
LATEST DEAL TYPE
1
INVESTORS
Description
Developer of novel immuno-oncology and immune-therapies intended for the treatment of haematologic malignancies and auto-immune diseases. The company's mmuno-oncology and immune-therapies enables blood cancers patient to have extended survival time from the disease.
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- Suite 145
- 4 Cornwallis Street
- Eveleigh, New South Wales 2015
- Australia
+61 (02) 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore HaemaLogiX’s full profile, request a free trial.
HaemaLogiX Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
HaemaLogiX Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Cicada Innovations | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
HaemaLogiX Executive Team (3)
HaemaLogiX Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Alan Liddle | HaemaLogiX | Board Member | 000 0000 | |
| Bryce Carmine | HaemaLogiX | Chief Executive Officer & Chairman | 000 0000 | |
| John Cullity | HaemaLogiX | Board Member | 000 0000 |